Bioprinting Markets And Alternatives Report 2022: Bioprinting Business Revenues To Attain Nearly $1.2 Billion By 2028

The “Bioprinting: Markets and Alternatives” report has been added to ResearchAndMarkets.com‘s providing.

Revenues from bioprinting are anticipated to succeed in virtually $1.2 billion in 2028, in contrast with simply $182 million at the moment. By 2028, the analyst expects virtually 70 p.c of the bioprinting business to come back from functions and repair revenues. The brand new report, “Bioprinting: Markets and Alternatives”, claims that we’re a few years from transplanting printed organs. Nonetheless, bioprinting is discovering a quickly rising software in drug and cosmetics testing. Utilizing printed tissues and organs avoids the necessity for animal testing and permits testing on printed tissue and organs which can be lifelike substitutes for the true factor.

Report Highlights

Manufacturing-grade bioprinters and reproducible bioprinting functions are coming to the fore. By 2031, R&D service revenues will clock up virtually $250 million in service/functions income for bioprinting, however this may nonetheless solely quantity to 12 p.c of whole service/functions revenues within the bioprinting business.

The analyst expects technological innovation throughout the complete bioprinting sector to speed up. The brand new report factors to a few developments particularly as areas of robust industrial potential. One in every of these is the arrival of organs-on-a-chip, a product class that bioprinting does a lot to allow. The report additionally predicts that bioprinters will transfer past the presently dominant extrusion and inkjet machines. Already as many as 20 novel methods of doing bioprinting are rising from main labs and healthcare services worldwide.

Whereas extrusion and inkjet bioprinters will account for properly over 90 p.c of bioprinter revenues in 2022, however by 2031, 15 p.c of bioprinter revenues will come from printers based mostly on fully novel printing applied sciences.
One other technical development that’s main bioprinting ahead technologically and can enhance prices to sufferers and increase capabilities is the development towards next-generation bioprinting platforms which have better capacities, automate a lot of the work, and combine medical performance properly past fundamental bioprinting. By 2031 the analyst expects manufacturing grade bioprinters or biomanufacturing platforms incorporating bioprinting to clock up round $100 million in revenues.

Key Matters Lined:

Chapter One: Overview

1.1 Background to Report: A Renaissance for Bioprinting?

1.2 Bioprinting: An Engaging Enterprise Alternative Going Ahead

1.2.1 Historical past and Prospects

1.2.2 Bioprinting Business Construction

1.2.3 Evolution of the Bioprinting Business

1.3 Geographical Variety of Firms

1.4 Purpose, Scope and Plan of this Report

1.5 Methodology of this Report

1.5.1 Forecasting Methodology and Assumptions

1.6 Key Factors from this Chapter

Chapter Two: Bioprinting: Market Drivers and Market Challenges

2.1 Components that Might Result in the “Bioprinting Second”

2.2 The COVID Issue: COVID as a Bioprinting Market Driver

2.3 The Growing older Inhabitants: The Function of Bioprinting

2.4 Bioprinting, Personalised Drugs and Bringing Healthcare Nearer to the Affected person

2.5 New Applied sciences Emerge For the reason that Earlier Bioprinting Second

2.5.1 Challenges to Technological Advances in Bioprinting

2.6 The Rising Potential for Modeling

2.7 Affect of Authorities Regulation and Funding

2.8 A Broader Vary of Bioinks

2.9 Moral Issues with Bioprinting

2.10 Key Factors from this Chapter

Chapter Three: Bioprinters: Technical and Market Evolution

3.1 The Essence of a Bioprinter

3.2 Extrusion Bioprinters

3.2.1 Examples of Extrusion Bioprinters

3.2.2 The Way forward for Extrusion-based Bioprinting

3.3 Inkjet Bioprinters

3.3.1 Thermal Inkjet for Bioprinting

3.3.2 Piezoelectric Inkjet for Bioprinting

3.3.3 The Rastrum Bioprinter: An Instance of an Inkjet Printer

3.4 Stereolithography (SLA)

3.4.1 The Downside with SLA-based Bioprinting

3.4.2 Producers of SLA Bioprinters

3.5 Different Bioprinting Applied sciences

3.6 Ten-year Forecasts of Bioprinter Markets by Printer Expertise and Printer Sort

3.6.1 From Analysis Bioprinting to Biofabrication: A Forecast

3.7 Key Factors from this Chapter

Chapter 4: Bioinks

4.1 Bioink Introductory

4.1.1 Scaffold-based and Scaffold-free Bioprinting

4.1.2 Hydrogels

4.1.3 Stem Cells and Bioprinting

4.1.4 Spheroids and Organoids

4.1.5 Ceramics and Bioprinting

4.1.6 A Be aware on Shear Printing

4.2 Forms of Bioinks: Performance

4.2.1 Sacrificial Bioinks

4.2.2 Practical Bioinks

4.2.3 Help Bioinks

4.3 Supplies for Bioinks

4.3.1 Agarose

4.3.2 Alginate

4.3.3 Collagen

4.3.4 Gelatin

4.3.5 GelMA

4.3.6 Chitosan

4.3.7 Hyaluronic Acid

4.3.8 dECM

4.3.9 Fibrin

4.3.10 Cellulose

4.3.11 Silk

4.3.12 Extracellular matrix (ECM)-based bioinks

4.3.13 Function of Artificial Polymers

4.3.14 Good Bioinks and Bioinks with Superior Materials Components

4.4 Phasing out Animal Supplies

4.5 Bioink Provide Chain and Suppliers

4.6 Key Factors from this Chapter

Chapter 5: Mainstream Bioprinting Functions

5.1 Bioprinting Functions Evaluation: Introductory

5.2 Bioprinting and Improved Medical Modeling

5.2.1 Organs-on-a-chip

5.2.2 Illness Modeling

5.3 Bioprinting Pores and skin

5.3.1 Background to Pores and skin Grafting

5.3.2 Bioprinting and Burn Victims

5.3.3 Bioinks for Pores and skin Bioprinting

5.3.4 Cosmetics Testing

5.4 Bone and Cartilage Printing

5.4.1 Supplies for Bone and Cartilage Printing

5.5 Organ Printing and Vascular Printing

5.5.1 Competitors Between Printed Organs and Residing Organs

5.5.2 Bladder Printing

5.5.3 Bioprinting and Breast Implants

5.5.4 Liver Printing

5.5.5 Endocrine System

5.5.6 A Printed Pancreas

5.5.7 Kidney Bioprinting

5.5.8 Lungs

5.5.9 Ears and Noses

5.5.10 Eyes

5.5.11 Hearts and Vasculature

5.5.12 Bioprinting and Neural Tissue

5.6 A Be aware on Dental Functions of Bioprinting

5.7 Key Factors from this Chapter

Chapter Six: New Instructions in Bioprinting

6.1 Introduction

6.2 Delicate Robotics

6.2.1 Delicate Robotics and Printing Utilizing Organic Supplies

6.3 Meals Printing

6.3.1 Drivers for Meals Printing

6.3.2 Meals Printers and Meals Design

6.3.3 Meals Printers Presently Out there

6.3.4 Bioprinting Meat

6.3.5 Printing Candies and Sweets

6.3.6 3D Printing-Themed Eating places

6.4. Capsule Printing

6.4.1 Manufacturing of Capsules Utilizing 3D Printing: Benefits and Disadvantages

6.4.2 Construction of a Rising Business

6.5 A Be aware on Medical Gadgets

6.6 Key Factors from this Report

Chapter Seven: Profiles of 9 Main Bioprinting Corporations and Their Methods

7.1 Standards for Profiling

7.2 3DBio Therapeutics: Full Bioprinting Bundle for Healthcare Suppliers

7.3 3D Methods/Systemic Bio: Nonetheless Feeling its Manner within the Bioprinting Enterprise?

7.4 BICO (Cellink): Bioconvergence Conglomerate

7.5 Cyfuse – Japanese Bioprinting Agency

7.6 EnvisionTEC/Desktop Steel: Extra Curiosity in Bioprinting

7.7 FluidForm – Constructing Ties to Essential Firms with Slicing Edge Expertise

7.8 Inventia Life Science: Breaking Out from R&D

7.9 Organovo Holdings: Extra Focus Than Earlier than

7.10 Rokit Healthcare – Korean Bioprinting and Google Cloud

Firms Talked about

3D Methods/Systemic Bio
3DBio Therapeutics
BICO (Cellink)
Cyfuse
EnvisionTEC/Desktop Steel
FluidForm
Inventia Life Science
Organovo Holdings
Rokit Healthcare

For extra details about this report go to https://www.researchandmarkets.com/r/bqwvxb